茂宸集团(00273.HK)拟2.68亿港元出售茂宸生殖科技64.85%股权
格隆汇2月26日丨茂宸集团(00273.HK)公告,于2020年2月26日,卖方茂宸医疗集团有限公司(公司间接全资附属公司)与买方同胜国际企业有限公司订立购股协议,卖方同意向买方出售目标公司茂宸生殖科技有限公司64.85%股权,现金代价为2.68亿港元。完成已于购股协议日期落实。
目标公司为一间投资控股公司,目标公司持有TWCGL约46.71%股权及TWCG Cayman 100%股权。TWCGL拥有六间于香港注册成立的全资附属公司及一间于香港注册成立的非全资附属公司及一间于英属处女群岛注册成立的全资附属公司,主要从事提供妇产科临床服务;体外人工受孕的体检及谘询、采集及胚胎测试业务;及血液测试、荷尔蒙测试及精子清洗实验室业务。TWCG Cayman并无经营业务,并预期将于2021年3月31日或前后自开曼群岛公司注册处剔除。
公司表示,鉴于新冠肺炎(COVID-19)爆发导致香港及全球经济下滑带来的经济不确定性,目标公司的财务表现受到不利影响。由于COVID-19爆发的持续不利影响,目标公司的前景仍未确定。集团认为,出售事项可透过资产重组收回资金,以优化其资本分配,从而加强集团控制风险的整体能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.